Skip to Main Content


Skip Nav Destination

IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

Cancer Research Communications (2023) 3 (4): 576–591.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Lars van der Veen
  • Michael Schmitt
  • Marcel A. Deken
  • Michael Lahn
International Journal of Toxicology (2023) 42 (6): 515.
  • Virender Kumar
  • Ram I. Mahato
Cancer Letters (2023) 579: 216462.
Close Modal

or Create an Account

Close Modal
Close Modal